J. Klosterkötter

发表

Evaluation of the ‘Jumping to conclusions’ bias in different subgroups of the at-risk mental state: from cognitive basic symptoms to UHR criteria

G. Juckel, F. Schneider, A. Heinz, 2016, Psychological Medicine.

Evidence of a smaller left hippocampus and left temporal horn in both patients with first episode schizophrenia and normal control subjects

Alexander Hammers, Armin Thron, Joachim Klosterkötter, 2000, Psychiatry Research: Neuroimaging.

Obsessive-Compulsive Disorder: Development of Demand-Controlled Deep Brain Stimulation with Methods from Stochastic Phase Resetting

F. Schneider, V. Sturm, P. Tass, 2003, Neuropsychopharmacology.

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.

G. Juckel, A. Heinz, J. Klosterkötter, 2010, Archives of general psychiatry.

German research network on schizophrenia

H. Möller, W. Maier, W. Gaebel, 2003, European Archives of Psychiatry and Clinical Neuroscience.

Deep Brain Stimulation in Schizophrenia

V. Sturm, P. Uhlhaas, D. Lenartz, 2014 .

The nucleus accumbens: a target for deep brain stimulation in obsessive–compulsive- and anxiety-disorders

V. Sturm, D. Lenartz, K. Herholz, 2003, Journal of Chemical Neuroanatomy.

Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia

K. Zilles, H. Freund, M. Hellmich, 2014, Molecular Psychiatry.

Neural correlates of temporal context discrimination

D. Donaldson, I. Tendolkar, G. Fernández, 2004, Biological Psychology.

Main Symptomatic Treatment Targets in Suspected and Early Psychosis: New Insights From Network Analysis.

K. Vogeley, E. Meisenzahl, R. Hornero, 2020, Schizophrenia bulletin.

Deep brain stimulation for psychiatric disorders.

Jens Kuhn, Joachim Klosterkötter, Volker Sturm, 2010, Deutsches Arzteblatt international.

Kraepelin and psychotic prodromal conditions

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2008, European Archives of Psychiatry and Clinical Neuroscience.

From Speech Illusions to Onset of Psychotic Disorder: Applying Network Analysis to an Experimental Measure of Aberrant Experiences

D. Borsboom, P. Delespaul, C. Pantelis, 2020, Schizophrenia Bulletin Open.

Psychotic disorders are associated with multiple social disabilities in work, study, independent living, interpersonal relations and self-care, and serious disability in functioning is one of the core features of the DSM–IV diagnosis of schizophrenia. Disability

G. Juckel, A. Heinz, J. Klosterkötter, 2010 .

Intervention in the at-risk state to prevent transition to psychosis

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2009, Current opinion in psychiatry.

Basic symptoms in schizophrenic and affective psychoses.

J. Klosterkötter, G. Huber, G. Gross, 1989, Psychopathology.

Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

M. Hellmich, J. Klosterkötter, D. Piomelli, 2012, Translational Psychiatry.

NEURAL CORRELATES OF VISUO-SPATIAL ATTENTION DURING AN ANTISACCADE TASK IN SCHIZOPHRENIA: AN ERP STUDY

I. Tendolkar, J. Klosterkötter, A. Brockhaus-Dumke, 2005, The International journal of neuroscience.

[Deep brain stimulation in schizophrenia].

V. Sturm, P. Uhlhaas, D. Lenartz, 2011, Fortschritte der Neurologie-Psychiatrie.

Diagnostic validity of basic symptoms

J. Klosterkötter, E. Steinmeyer, F. Schultze-Lutter, 2005, European Archives of Psychiatry and Clinical Neuroscience.

Morphometry of structural disconnectivity indicators in subjects at risk and in age-matched patients with schizophrenia

K. Vogeley, J. Klosterkötter, S. Ruhrmann, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Predicting the onset of schizophrenia

J. Klosterkötter, 2002 .

Survey of the European Psychiatric Association on the European status and perspectives in early detection and intervention in at‐risk mental state and first‐episode psychosis

A. Riecher-Rössler, J. Klosterkötter, M. Rojnić-Kuzman, 2018, Early intervention in psychiatry.

Antibodies to infectious agents in individuals with recent onset schizophrenia

R. Yolken, E. Torrey, J. Klosterkötter, 2004, European Archives of Psychiatry and Clinical Neuroscience.

Expressed emotion as a predictor of the first psychotic episode — Results of the European prediction of psychosis study

Georg Juckel, Stephan Ruhrmann, Joachim Klosterkötter, 2018, Schizophrenia Research.

Oxcarbazepine--efficacy and tolerability during treatment of alcohol withdrawal: a double-blind, randomized, placebo-controlled multicenter pilot study.

W. Gaebel, J. Klosterkötter, D. Koethe, 2007, Alcoholism, clinical and experimental research.

One-year functional outcomes of naturalistically treated patients with schizophrenia

H. Möller, W. Maier, I. Heuser, 2012, Psychiatry Research.

Basic symptoms and the prediction of first-episode psychosis.

J. Klosterkötter, A. Bechdolf, P. Fusar-Poli, 2012, Current pharmaceutical design.

Serum amino acids, central monoamines, and hormones in drug-naive, drug-free, and neuroleptic-treated schizophrenic patients and healthy subjects

P. Bräunig, J. Klosterkötter, G. Huber, 1990, Psychiatry Research.

WC1C DEVELOPMENT AND EVALUATION OF THE SCHIZOPHRENIA PRONENESS INSTRUMENT, ADULT VERSION (SPI-A)

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2006, Schizophrenia Research.

Self-experienced vulnerability, prodromal symptoms and coping strategies preceding schizophrenic and depressive relapses

J. Klosterkötter, A. Bechdolf, F. Schultze-Lutter, 2002, European Psychiatry.

Does Clinical Judgment of Baseline Severity and Changes in Psychopathology Depend on the Patient Population?: Results of a CGI and PANSS Linking Analysis in a Naturalistic Study

H. Möller, W. Maier, I. Heuser, 2010, Journal of clinical psychopharmacology.

Predictors of relapse in the year after hospital discharge among patients with schizophrenia.

H. Möller, W. Maier, I. Heuser, 2012, Psychiatric services.

Akathisia and Suicidal Ideation in First-Episode Schizophrenia

H. Möller, F. Schneider, W. Maier, 2012, Journal of clinical psychopharmacology.

[Establishment of an Animal Based Therapy at a University Hospital for Psychiatry: Results of a Preliminary Study and Future Prospects].

J. Kuhn, J. Klosterkötter, M. Bodatsch, 2015, Psychiatrische Praxis.

Basic Disturbances of Information Processing in Psychosis Prediction

J. Klosterkötter, S. Ruhrmann, M. Bodatsch, 2013, Front. Psychiatry.

Microbiota is essential for social development in the mouse

V. Sturm, D. Lenartz, J. Kuhn, 2013 .

Prediction of symptom remission in schizophrenia during inpatient treatment

H. Möller, I. Heuser, E. Rüther, 2009, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Intervention in at-risk states for developing psychosis

J. Klosterkötter, A. Bechdolf, S. Ruhrmann, 2010, European Archives of Psychiatry and Clinical Neuroscience.

Internal capsule size associated with outcome in first-episode schizophrenia

H. Möller, F. Schneider, T. Schneider-Axmann, 2009, European Archives of Psychiatry and Clinical Neuroscience.

Prevalence of metabolic syndrome in female and male patients at risk of psychosis

G. Juckel, F. Schneider, W. Maier, 2017, Schizophrenia Research.

[Cerebral pseudotumour with psychic disturbances and unfavorable prognosis].

J. Klosterkötter, 1982, Der Nervenarzt.

Physical illnesses, developmental risk factors and psychiatric diagnoses among subjects at risk of psychosis

G. Juckel, J. Klosterkötter, D. Linszen, 2013, European Psychiatry.

Motor Improvement and Emotional Stabilization in Patients With Tourette Syndrome After Deep Brain Stimulation of the Ventral Anterior and Ventrolateral Motor Part of the Thalamus

V. Visser-Vandewalle, V. Sturm, L. Timmermann, 2016, Biological Psychiatry.

Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis

A. Meyer-Lindenberg, G. Juckel, P. Falkai, 2022, Schizophrenia.

Psychosis-predictive value of self-reported schizotypy in a clinical high-risk sample.

D. Hubl, M. Debbané, J. Klosterkötter, 2016, Journal of abnormal psychology.

Early detection of psychosis – Establishing a service for persons at risk

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2009, European Psychiatry.

Poster #T160 A STRATIFIED MODEL FOR PSYCHOSIS PREDICTION IN CLINICAL PRACTICE

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2014, Schizophrenia Research.

A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in patients with schizophrenia

J. Klosterkötter, A. Bechdolf, B. Knost, 2004, Acta psychiatrica Scandinavica.

Psychosis‐risk criteria in the general population: frequent misinterpretations and current evidence

W. Gaebel, J. Klosterkötter, F. Schultze-Lutter, 2018, World psychiatry : official journal of the World Psychiatric Association.

Early detection of schizophrenia

J. Klosterkötter, 2011 .

Short-term functional outcome and premorbid adjustment in clinical high-risk patients. Results of the EPOS project

G. Juckel, J. Hietala, J. Klosterkötter, 2014, European Psychiatry.

[Is the diagnosis of schizophrenic illness possible in the initial prodromal phase to the first psychotic manifestation?].

M. Hellmich, J. Klosterkötter, F. Schultze-Lutter, 2000, Fortschritte der Neurologie-Psychiatrie.

Standardized remission criteria in schizophrenia: descriptive validity and comparability with previously used outcome measures.

H. Möller, I. Heuser, E. Rüther, 2008, Pharmacopsychiatry.

Personality dimensions in persons symptomatically at risk of psychosis: pronounced but lacking a characteristic profile

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2015, Early intervention in psychiatry.

Axis I diagnoses and transition to psychosis in clinical high-risk patients EPOS project: Prospective follow-up of 245 clinical high-risk outpatients in four countries

G. Juckel, J. Klosterkötter, D. Linszen, 2012, Schizophrenia Research.

Diagnose und Prognose in der Psychiatrie

J. Klosterkötter, 2004, Fortschritte der Neurologie-Psychiatrie.

Child Maltreatment and Clinical Outcome in Individuals at Ultra-High Risk for Psychosis

J. Os, F. Smit, P. McGuire, 2020 .

Pathways to care in subjects at high risk for psychotic disorders — A European perspective

G. Juckel, A. Heinz, J. Klosterkötter, 2014, Schizophrenia Research.

Time course of antipsychotic treatment response in schizophrenia: Results from a naturalistic study in 280 patients

I. Heuser, E. Rüther, W. Gaebel, 2010, Schizophrenia Research.

What are depressive symptoms in acutely ill patients with schizophrenia spectrum disorder?

H. Möller, W. Maier, I. Heuser, 2015, European Psychiatry.

What are residual symptoms in schizophrenia spectrum disorder? Clinical description and 1-year persistence within a naturalistic trial

H. Möller, W. Maier, I. Heuser, 2015, European Archives of Psychiatry and Clinical Neuroscience.

Antipsychotic Effects of Cannabidiol

M. Hellmich, J. Klosterkötter, D. Piomelli, 2009, European Psychiatry.

Childhood adversity predicts persistence of suicidal thoughts differently in females and males at clinical high‐risk patients of psychosis. Results of the EPOS project

G. Juckel, J. Hietala, J. Klosterkötter, 2018, Early intervention in psychiatry.

Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis.

M. Hellmich, J. Klosterkötter, D. Piomelli, 2009, The British journal of psychiatry : the journal of mental science.

Poster #202 COMPARING THE PRODROME OF SCHIZOPHRENIA-SPECTRUM PSYCHOSES AND BIPOLAR DISORDERS WITH AND WITHOUT PSYCHOTIC FEATURES

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2012, Schizophrenia Research.

Familiality of obsessive-compulsive disorder in nonclinical and clinical subjects.

U. John, P. Falkai, W. Maier, 2006, The American journal of psychiatry.

Determination of anandamide and other fatty acyl ethanolamides in human serum by electrospray tandem mass spectrometry.

J. Klosterkötter, D. Piomelli, U. Jaehde, 2007, Analytical biochemistry.

Predicting first-episode psychosis by basic symptom criteria.

J. Klosterkötter, E. Steinmeyer, S. Ruhrmann, 2007 .

Diagnosing schizophrenia in the prodromal phase

J. Klosterkötter, F. Schultze-Lutter, 1998, European Psychiatry.

Changes in nutritional status after deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s disease — Results of a phase I study

H. Freund, V. Visser-Vandewalle, M. Hellmich, 2015, The journal of nutrition, health & aging.

Pharmacological intervention in the initial prodromal phase of psychosis

W. Maier, J. Klosterkötter, S. Ruhrmann, 2005, European Psychiatry.

Course of clinical high-risk states for psychosis beyond conversion

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2018, European Archives of Psychiatry and Clinical Neuroscience.

Psychosocial outcome in patients at clinical high risk of psychosis: a prospective follow-up

G. Juckel, J. Klosterkötter, D. Linszen, 2013, Social Psychiatry and Psychiatric Epidemiology.

[Suicidology and Covid-19 Pandemic].

J. Klosterkötter, Jens Kuhn, 2022, Fortschritte der Neurologie-Psychiatrie.

Concept and Results of the German Research Network on Schizophrenia

W. Gaebel, W. Wölwer, J. Klosterkötter, 2018 .

Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid

M. Hellmich, R. Graf, J. Klosterkötter, 2009, Journal of Neural Transmission.

European status and perspectives on early detection and intervention in at-risk mental state and first episode psychosis: Viewpoint from the EPA section for prevention of mental disorders

A. Riecher-Rössler, J. Klosterkötter, A. Raballo, 2017, European Psychiatry.

[For: "Every person with schizophrenia should be treated as early as possible"].

J. Klosterkötter, 2006, Psychiatrische Praxis.

Early Detection of Psychosis - State of the Art and Future Perspectives

J. Klosterkötter, 2016 .

Obsessive–compulsive symptoms in at‐risk mental states for psychosis: associations with clinical impairment and cognitive function

G. Juckel, F. Schneider, W. Maier, 2014, Acta psychiatrica Scandinavica.

[Early course of illness in first episode schizophrenia with long duration of untreated illness - a comparative study].

W. Maier, J. Klosterkötter, A. Bechdolf, 2004, Fortschritte der Neurologie-Psychiatrie.

The Meaning of Basic Symptoms for the Genesis of the Schizophrenic Nuclear Syndrome

J. Klosterkötter, 1992, The Japanese journal of psychiatry and neurology.

Disturbances of visual information processing in early states of psychosis and experimental delta-9-tetrahydrocannabinol altered states of consciousness

Joachim Klosterkötter, Hinderk M. Emrich, Dagmar Koethe, 2006, Schizophrenia Research.

Cannabis-Associated Psychosis

J. Klosterkötter, F. Leweke, F. Leweke, 2004, CNS drugs.

Can quantitative EEG measures predict clinical outcome in subjects at Clinical High Risk for psychosis? A prospective multicenter study

Lo J. Bour, Stephan Ruhrmann, Joachim Klosterkötter, 2014, Schizophrenia Research.

The psychosis high-risk state: a comprehensive state-of-the-art review.

T. McGlashan, M. Keshavan, P. McGuire, 2013, JAMA psychiatry.

Diagnosing schizophrenia in the initial prodromal phase

J. Klosterkötter, E. Steinmeyer, F. Schultze-Lutter, 2000, Schizophrenia Research.

Prediction and Early Detection of First-Episode Psychosis

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2011 .

Preventing progression to first-episode psychosis in early initial prodromal states

W. Maier, W. Gaebel, B. Janssen, 2012, British Journal of Psychiatry.

Atropine-sensitive hippocampal theta oscillations are mediated by Cav2.3 R-type Ca2+ channels

J. Klosterkötter, K. Broich, A. Brockhaus-Dumke, 2012, Neuroscience.

Atropine-sensitive hippocampal theta oscillations are mediated by Cav2.3 R-type Ca2+ channels

J. Klosterkötter, K. Broich, A. Brockhaus-Dumke, 2012, Neuroscience.

Remembering or knowing: electrophysiological evidence for an episodic memory deficit in schizophrenia

I. Tendolkar, J. Klosterkötter, S. Ruhrmann, 2002, Psychological Medicine.

Prepulse inhibition in psychiatric disorders--apart from schizophrenia.

K. Heekeren, J. Kuhn, S. Kohl, 2013, Journal of psychiatric research.

Early onset of obsessive–compulsive disorder and associated comorbidity

U. John, P. Falkai, W. Maier, 2009, Depression and anxiety.

The interrelationship between schizotypy, clinical high risk for psychosis and related symptoms: Cognitive disturbances matter

K. Vogeley, D. Hubl, P. Grant, 2019, Schizophrenia Research.

The initial prodrome of schizophrenia: different duration, different underlying deficits?

J. Klosterkötter, F. Leweke, S. Ruhrmann, 2007, Comprehensive psychiatry.

Increased neural response related to neutral faces in individuals at risk for psychosis

Nadim Joni Shah, Tilo Kircher, Ute Habel, 2008, NeuroImage.

EPA guidance on the early detection of clinical high risk states of psychoses

M. Nordentoft, A. Riecher-Rössler, J. Klosterkötter, 2015, European Psychiatry.

EPA guidance on the early intervention in clinical high risk states of psychoses

M. Nordentoft, A. Riecher-Rössler, J. Klosterkötter, 2015, European Psychiatry.

Indicated prevention of schizophrenia.

J. Klosterkötter, 2008, Deutsches Arzteblatt international.

Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients: Impact of cannabis use

M. Hellmich, J. Klosterkötter, D. Piomelli, 2007, Schizophrenia Research.

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.

D. Rujescu, R. Murray, M. Ruggeri, 2014, Schizophrenia bulletin.

[Mental health of children, adolescents and young adults--part 2: burden of illness, deficits of the German health care system and efficacy and effectiveness of early intervention services].

G. Juckel, M. Bauer, A. Pfennig, 2013, Fortschritte der Neurologie-Psychiatrie.

Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder – When, Who, and How?

H. Möller, W. Maier, I. Heuser, 2017, Pharmacopsychiatry.

[Anti-NMDA receptor encephalitis: a neurological and psychiatric emergency].

G. Fink, J. Klosterkötter, D. Pedrosa, 2012, Fortschritte der Neurologie-Psychiatrie.

Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.

H. Möller, J. Brinkmeyer, W. Maier, 2011, Schizophrenia bulletin.

Early detection and secondary prevention of psychosis: facts and visions*

H. Möller, W. Maier, W. Gaebel, 2004, European Archives of Psychiatry and Clinical Neuroscience.

5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option

P. Falkai, W. Maier, H. Grabe, 2014, European Neuropsychopharmacology.

Cognitive functioning throughout adulthood and illness stages in individuals with psychotic disorders and their unaffected siblings

Peter B. Jones, R. Murray, S. Tosato, 2021, Molecular Psychiatry.

At risk or not at risk? A meta‐analysis of the prognostic accuracy of psychometric interviews for psychosis prediction

T. McGlashan, S. Woods, P. McGuire, 2015, World psychiatry : official journal of the World Psychiatric Association.

Dysregulated Lipid Metabolism Precedes Onset of Psychosis

P. Delespaul, C. Pantelis, M. Krebs, 2020, Biological Psychiatry.

Deficient Inhibitory Cortical Networks in Antipsychotic-Naive Subjects at Risk of Developing First-Episode Psychosis and First-Episode Schizophrenia Patients: A Cross-Sectional Study

Christian Grefkes, Alkomiet Hasan, Peter Falkai, 2012, Biological Psychiatry.

Clinical, cognitive and neuroanatomical associations of serum NMDAR autoantibodies in people at clinical high risk for psychosis

M. Hotopf, A. David, P. Delespaul, 2020, Molecular Psychiatry.

Recent approaches to psychological interventions for people at risk of psychosis

J. Klosterkötter, A. Bechdolf, L. Phillips, 2006, European Archives of Psychiatry and Clinical Neuroscience.

The interaction of working memory and emotion in persons clinically at risk for psychosis: An fMRI pilot study

U. Habel, F. Schneider, T. Kellermann, 2010, Schizophrenia Research.

Multimodal prevention of first psychotic episode through N‐acetyl‐l‐cysteine and integrated preventive psychological intervention in individuals clinically at high risk for psychosis: Protocol of a randomized, placebo‐controlled, parallel‐group trial

J. Schultz, A. Meyer-Lindenberg, W. Maier, 2019, Early intervention in psychiatry.

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis Paolo Fusar-Poli*,1–3, Frauke Schultze-Lutter4, Marco Cappucciati1,3, Grazia Rutigliano1, Ilaria Bonoldi1–3, Daniel Stahl5, Stephan Borgwardt6, Anita Riecher-R

T. McGlashan, S. Woods, P. McGuire, 2015 .

Probably at-risk, but certainly ill — Advocating the introduction of a psychosis spectrum disorder in DSM-V

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2010, Schizophrenia Research.

CSF Metabolic and Proteomic Profiles in Patients Prodromal for Psychosis

J. Klosterkötter, E. Holmes, S. Bahn, 2007, PloS one.

Early self‐experienced neuropsychological deficits and subsequent schizophrenic diseases: an 8‐year average follow‐up prospective study

G Huber, J. Klosterkötter, E. Steinmeyer, 1997, Acta psychiatrica Scandinavica.

Prepsychotic phase of schizophrenia and related disorders: recent progress and future opportunities

J. Klosterkötter, B. Cornblatt, A. Yung, 2005, British Journal of Psychiatry.

Attitude towards adherence in patients with schizophrenia at discharge.

H. Möller, W. Maier, I. Heuser, 2009, Journal of psychiatric research.

The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.

P. Falkai, W. Maier, H. Grabe, 2013, The international journal of neuropsychopharmacology.

Insight in schizophrenia–course and predictors during the acute treatment phase of patients suffering from a schizophrenia spectrum disorder

H. Möller, W. Maier, I. Heuser, 2012, European Psychiatry.

Intervention in individuals at ultra-high risk for psychosis: a review and future directions.

I. Hickie, M. Keshavan, P. McGuire, 2009, The Journal of clinical psychiatry.

Neurocognitive Functioning in Subjects at Risk for a First Episode of Psychosis Compared with First- and Multiple-episode Schizophrenia

I. Tendolkar, J. Klosterkötter, A. Bechdolf, 2006, Journal of clinical and experimental neuropsychology.

The European Prediction of Psychosis Study (EPOS): integrating early recognition and intervention in Europe.

Georg Juckel, Stephan Ruhrmann, Joachim Klosterkötter, 2005, World psychiatry : official journal of the World Psychiatric Association.

Basic symptoms and ultrahigh risk criteria: symptom development in the initial prodromal state.

W. Maier, J. Klosterkötter, S. Ruhrmann, 2010, Schizophrenia bulletin.

Evaluating Depressive Symptoms in Schizophrenia: A Psychometric Comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale

H. Möller, W. Maier, I. Heuser, 2012, Psychopathology.

Acute effects of treatment for prodromal Acute effects of treatment for prodromal symptoms for people putatively in a late initial symptoms for people putatively in a late initial

W. Gaebel, B. Janssen, J. Klosterkötter, 2007 .

Neurocognitive indicators for a conversion to psychosis: Comparison of patients in a potentially initial prodromal state who did or did not convert to a psychosis

J. Klosterkötter, A. Bechdolf, A. Brockhaus-Dumke, 2007, Schizophrenia Research.

Early Detection and Intervention in the Initial Prodromal Phase of Schizophrenia

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2003, Pharmacopsychiatry.

[Pathways to care: help-seeking behavior in first-episode psychosis].

W. Maier, J. Klosterkötter, A. Bechdolf, 2004, Fortschritte der Neurologie-Psychiatrie.

Negative schemata about the self and others and paranoid ideation in at‐risk states and those with persisting positive symptoms

G. Juckel, F. Schneider, W. Maier, 2018, Early intervention in psychiatry.

Clinical high risk for psychosis: gender differences in symptoms and social functioning

Michael Wagner, Andreas Heinz, Georg Juckel, 2017, Early intervention in psychiatry.

Neurocognitive Indicators of Clinical High-Risk States for Psychosis: A Critical Review of the Evidence

J. Klosterkötter, R. Pukrop, 2010, Neurotoxicity Research.

DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis

M. Rietschel, P. Falkai, W. Maier, 2009, European Archives of Psychiatry and Clinical Neuroscience.

Personality disorders and accentuations in at‐risk persons with and without conversion to first‐episode psychosis

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2012, Early intervention in psychiatry.

Auditory P300 in individuals clinically at risk for psychosis.

J. Brinkmeyer, W. Maier, W. Wölwer, 2008, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

Prediction of psychosis in clinical high-risk patients by the Schizotypal Personality Questionnaire. Results of the EPOS project

G. Juckel, J. Hietala, J. Klosterkötter, 2013, European Psychiatry.

Whither the attenuated psychosis syndrome?

Tyrone D. Cannon, T. McGlashan, M. Keshavan, 2012, Schizophrenia bulletin.

Chances and risks of predicting psychosis

J. Klosterkötter, S. Ruhrmann, M. Bodatsch, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosis

G. Juckel, A. Heinz, J. Klosterkötter, 2012, Acta psychiatrica Scandinavica.

Perceived negative attitude of others as an early sign of psychosis

J. Huttunen, J. Hietala, J. Klosterkötter, 2009, European Psychiatry.

Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic

J. Klosterkötter, M. Hambrecht, R. Pukrop, 2002, British Journal of Psychiatry.

Depression predicts persistence of paranoia in clinical high-risk patients to psychosis: results of the EPOS project

G. Juckel, J. Hietala, J. Klosterkötter, 2016, Social Psychiatry and Psychiatric Epidemiology.

Deep Brain Stimulation in Schizophrenia

P. Uhlhaas, D. Lenartz, C. Winter, 2014, Fortschritte der Neurologie-Psychiatrie.

Prevention and Early Intervention in At-Risk States for Developing Psychosis

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2011 .

[Social Anxiety in individuals with clinical high-risk state for psychosis].

J. Klosterkötter, M. Rosen, T. Haidl, 2018, Fortschritte der Neurologie-Psychiatrie.

Comparing the prodrome of schizophrenia-spectrum psychoses and affective disorders with and without psychotic features

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2012, Schizophrenia Research.

Reduced subjective quality of life in persons at risk for psychosis

W. Maier, W. Gaebel, B. Janssen, 2008, Acta psychiatrica Scandinavica.

Impaired mismatch negativity generation in prodromal subjects and patients with schizophrenia

I. Tendolkar, J. Klosterkötter, A. Brockhaus-Dumke, 2005, Schizophrenia Research.

The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response.

W. Maier, W. Gaebel, W. Wölwer, 2012, The international journal of neuropsychopharmacology.

Antisaccade performance is related to genetic loading for schizophrenia.

W. Maier, U. Ettinger, M. Wagner, 2009, Journal of psychiatric research.

Self-Reported Psychotic-Like Experiences Are a Poor Estimate of Clinician-Rated Attenuated and Frank Delusions and Hallucinations

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2013, Psychopathology.

Rationale and first results of developing at-risk (prodromal) criteria for bipolar disorder.

M. Berk, J. Klosterkötter, A. Bechdolf, 2012, Current pharmaceutical design.

[Mental health of children, adolescents and young adults--part 1: prevalence, illness persistence, adversities, service use, treatment delay and consequences].

G. Juckel, M. Bauer, A. Pfennig, 2013, Fortschritte der Neurologie-Psychiatrie.

Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms

Joachim Klosterkötter, Dagmar Koethe, Daniele Piomelli, 2004, Neuropsychopharmacology.

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

H. Möller, F. Schneider, I. Heuser, 2011, European Neuropsychopharmacology.

Antisaccade and prosaccade eye movements in individuals clinically at risk for psychosis: comparison with first-episode schizophrenia and prediction of conversion

W. Maier, W. Gaebel, W. Wölwer, 2019, European Archives of Psychiatry and Clinical Neuroscience.

Remission and Recovery and their Predictors in Schizophrenia Spectrum Disorder: Results from a 1-Year Follow-Up Naturalistic Trial

H. Möller, W. Maier, I. Heuser, 2012, Psychiatric Quarterly.

Subjective quality of life in subjects at risk for a first episode of psychosis: A comparison with first episode schizophrenia patients and healthy controls

J. Klosterkötter, A. Bechdolf, S. Ruhrmann, 2005, Schizophrenia Research.

German research network on schizophrenia-bridging the gap between research and care.

H. Möller, W. Maier, W. Gaebel, 2003, European archives of psychiatry and clinical neuroscience.

Prediction of Psychosis by Mismatch Negativity

Michael Wagner, Stephan Ruhrmann, Joachim Klosterkötter, 2011, Biological Psychiatry.

Stimulating the Addictive Brain

J. Kuhn, J. Klosterkötter, T. Gruendler, 2012, Front. Hum. Neurosci..

Prepulse Inhibition of the Acoustic Startle Reflex in High Functioning Autism

K. Vogeley, J. Kuhn, S. Kohl, 2014, PloS one.

[New Challenges for Psychiatry].

J. Klosterkötter, 2017, Fortschritte der Neurologie-Psychiatrie.

Evidence for a dysfunctional retrosplenial cortex in patients with schizophrenia: a functional magnetic resonance imaging study with a semantic—perceptual contrast

K. Specht, I. Tendolkar, G. Fernández, 2004, Neuroscience Letters.

Title Anandamide levels in cerebrospinal fluid of first-episode schizophrenic patients : Impact of cannabis use Permalink

M. Hellmich, J. Klosterkötter, D. Piomelli, 2007 .

Dimensions of working memory dysfunction in schizophrenia

I. Tendolkar, J. Klosterkötter, A. Brockhaus-Dumke, 2003, Schizophrenia Research.

Outcome of suicidal patients with schizophrenia: results from a naturalistic study

H. Möller, W. Maier, I. Heuser, 2010, Acta psychiatrica Scandinavica.

Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.

F. Schneider, W. Maier, A. Heinz, 2011, Schizophrenia bulletin.

Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin

J. Aldenhoff, P. Falkai, W. Maier, 2007, Molecular Psychiatry.

Coping and the stages of psychosis: an investigation into the coping styles in people at risk of psychosis, in people with first‐episode and multiple‐episode psychoses

J. Klosterkötter, A. Bechdolf, S. Gross, 2017, Early intervention in psychiatry.

[Is there a primary prevention of schizophrenic psychiasis?].

J. Klosterkötter, F. Schultze-Lutter, 2001, Fortschritte der Neurologie-Psychiatrie.

Cognitive-Behavioral Group Therapy for Schizophrenia

J. Klosterkötter, S. Schiller, 2006 .

Duration of unspecific prodromal and clinical high risk states, and early help-seeking in first-admission psychosis patients

W. Maier, J. Klosterkötter, S. Ruhrmann, 2015, Social Psychiatry and Psychiatric Epidemiology.

[Psychiatric classification. Basic idea and development of an ongoing process].

J. Klosterkötter, 1999, Fortschritte der Neurologie-Psychiatrie.

[Schizophrenia simplex--does it exist?].

J. Klosterkötter, 1983, Der Nervenarzt.

[Association psychology versus learning psychology theory of schizophrenia (author's transl)].

J. Klosterkötter, 1982, Fortschritte der Neurologie-Psychiatrie.

[Successful electroconvulsive therapy of Cotard syndrome with bitemporal hypoperfusion].

J. Klosterkötter, O. Sabri, K. Nishimura, 1996, Der Nervenarzt.

Coping as a predictor of treatment outcome in people at clinical high risk of psychosis

H. Möller, W. Maier, W. Gaebel, 2016, Early intervention in psychiatry.

Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders

M. Hellmich, J. Klosterkötter, C. Schmahl, 2014, European Archives of Psychiatry and Clinical Neuroscience.

Clinical effectiveness of unilateral deep brain stimulation in Tourette syndrome

V. Sturm, D. Lenartz, S. Hunsche, 2011, Translational Psychiatry.

Deep Brain Stimulation as a Tool for Improving Cognitive Functioning in Alzheimer’s Dementia: A Systematic Review

V. Visser-Vandewalle, D. Lenartz, J. Kuhn, 2013, Front. Psychiatry.

Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.

H. Möller, Florian Wickelmaier, F. Schneider, 2008, The international journal of neuropsychopharmacology.

The German Research Network on Schizophrenia-impact on the management of schizophrenia

H. Möller, W. Maier, W. Gaebel, 2006, Dialogues in Clinical Neuroscience.

Unilateral deep brain stimulation of the nucleus accumbens in patients with treatment-resistant obsessive-compulsive disorder: Outcomes after one year

V. Sturm, D. Lenartz, J. Kuhn, 2010, Clinical Neurology and Neurosurgery.

["Fortschritte" opens new platform for english language submissions].

J. Klosterkötter, 2012, Fortschritte der Neurologie-Psychiatrie.

J. Klosterkötter, A. Bechdolf, R. Pukrop, 2007 .

Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depression

H. Möller, J. Klosterkötter, M. Albus, 2003, Psychiatry Research.

Restricted attention to social cues in schizophrenia patients

Stephan Ruhrmann, Joachim Klosterkötter, J. Klosterkötter, 2016, European Archives of Psychiatry and Clinical Neuroscience.

Alexithymia in Obsessive-Compulsive Disorder – Results from a Family Study

U. John, P. Falkai, W. Maier, 2006, Psychotherapy and Psychosomatics.

Quality of life and subjective well-being in schizophrenia and schizophrenia spectrum disorders: Valid predictors of symptomatic response and remission?

H. Möller, I. Heuser, E. Rüther, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[Depression Treatment in Old Age].

J. Klosterkötter, 2015, Fortschritte der Neurologie Psychiatrie.

Contributions of Experimental Psychiatry to Research on the Psychosis Prodrome

J. Klosterkötter, J. Daumann, M. Bodatsch, 2013, Front. Psychiatry.

A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis

W. Maier, W. Gaebel, W. Wölwer, 2012, European Archives of Psychiatry and Clinical Neuroscience.

What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a “real-world” 2-year follow-up trial

H. Möller, W. Maier, I. Heuser, 2019, European Archives of Psychiatry and Clinical Neuroscience.

Cognitive and emotional empathy in individuals at clinical high risk of psychosis

C. Montag, G. Juckel, F. Schneider, 2020, Acta psychiatrica Scandinavica.

Obsessive-Compulsive Symptoms and Other Symptoms of the At-risk Mental State for Psychosis: A Network Perspective

D. Borsboom, P. McGuire, P. Delespaul, 2021, Schizophrenia bulletin.

Interventions in the initial prodromal states of psychosis in Germany: concept and recruitment

W. Maier, M. Wagner, B. Janssen, 2005, British Journal of Psychiatry.

A randomized comparison of group cognitive‐behavioural therapy and group psychoeducation in acute patients with schizophrenia: outcome at 24 months

J. Klosterkötter, A. Bechdolf, B. Knost, 2005, Acta psychiatrica Scandinavica.

Perceived negative attitude of others predicts transition to psychosis in patients at risk of psychosis

G. Juckel, J. Klosterkötter, D. Linszen, 2012, European Psychiatry.

An early improvement threshold to predict response and remission in first-episode schizophrenia

H. Möller, F. Schneider, W. Maier, 2010, British Journal of Psychiatry.

Pharmacological prevention and treatment in clinical at-risk states for psychosis.

J. Klosterkötter, A. Bechdolf, S. Ruhrmann, 2012, Current pharmaceutical design.

Forecasting Psychosis by Event-Related Potentials—Systematic Review and Specific Meta-Analysis

J. Klosterkötter, A. Brockhaus-Dumke, S. Ruhrmann, 2015, Biological Psychiatry.

Disability in people clinically at high risk of psychosis

G. Juckel, A. Heinz, J. Klosterkötter, 2010, British Journal of Psychiatry.

The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosis

G. Juckel, A. Heinz, J. Klosterkötter, 2012, Acta psychiatrica Scandinavica.

Predictors of treatment response to psychological interventions in people at clinical high risk of first‐episode psychosis

H. Möller, W. Maier, W. Gaebel, 2019, Early intervention in psychiatry.

Evaluation of the German WPA “Program against stigma and discrimination because of schizophrenia — Open the Doors”: Results from representative telephone surveys before and after three years of antistigma interventions

H. Möller, W. Maier, W. Gaebel, 2008, Schizophrenia Research.

Response and remission of subjective well-being in patients suffering from schizophrenia spectrum disorders

H. Möller, W. Maier, I. Heuser, 2011, European Psychiatry.

Determinants of subjective quality of life in post acute patients with schizophrenia

J. Klosterkötter, A. Bechdolf, B. Knost, 2003, European Archives of Psychiatry and Clinical Neuroscience.

Antisaccade performance in patients with obsessive–compulsive disorder and unaffected relatives: further evidence for impaired response inhibition as a candidate endophenotype

P. Falkai, W. Maier, M. Wagner, 2012, European Archives of Psychiatry and Clinical Neuroscience.

Impulsiveness in obsessive–compulsive disorder: results from a family study

P Falkai, P. Falkai, W. Maier, 2007, Acta psychiatrica Scandinavica.

BSABS : Bonn scale for the assessment of basic symptoms : manual, commentary, references, index, documentation sheet

J. Klosterkötter, G. Huber, G. Gross, 2008 .

Basic symptoms in early psychotic and depressive disorders.

J. Klosterkötter, A. Brockhaus-Dumke, S. Ruhrmann, 2007, The British journal of psychiatry. Supplement.

Pharmacological treatment of deep brain stimulation-induced hypomania leads to clinical remission while preserving motor benefits

P. Weiss, L. Timmermann, L. Schilbach, 2012, Neurocase.

Prediction and prevention of psychosis: current progress and future tasks

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2014, European Archives of Psychiatry and Clinical Neuroscience.

Successful deep brain stimulation of the nucleus accumbens in severe alcohol dependence is associated with changed performance monitoring

V. Sturm, D. Lenartz, M. Ullsperger, 2011, Addiction biology.

Stigma experiences and perceived stigma in patients with first-episode schizophrenia in the course of 1 year after their first in-patient treatment

H. Möller, W. Maier, W. Gaebel, 2019, European Archives of Psychiatry and Clinical Neuroscience.

[Deep brain stimulation in the context of addiction--a literature-based systematic evaluation].

J. Kuhn, J. Klosterkötter, R. Bauer, 2008, Fortschritte der Neurologie-Psychiatrie.

Obituary Gerd Huber (*03.12.1921 †08.04.2012)

J. Klosterkötter, K. Bechter, 2013 .

Improving the clinical prediction of psychosis by combining ultra-high risk criteria and cognitive basic symptoms

Stephan Ruhrmann, Joachim Klosterkötter, Frauke Schultze-Lutter, 2014, Schizophrenia Research.

[Changes in the public's social distance toward individuals with schizophrenia in six German cities. Results of representative pre- and postinterventional telephone surveys from 2001 to 2004].

W. Gaebel, J. Klosterkötter, P. Decker, 2007, Der Nervenarzt.

[A telephone hotline as an easily accessible service for questions on schizophrenia].

W. Gaebel, W. Wölwer, J. Klosterkötter, 2006, Der Nervenarzt.

Cognitive-behavioral therapy in the pre-psychotic phase: An exploratory study

B. Janssen, J. Klosterkötter, A. Bechdolf, 2005, Psychiatry Research.

Stress reactivity as a putative mechanism linking childhood trauma with clinical outcomes in individuals at ultra-high-risk for psychosis: Findings from the EU-GEI High Risk Study

C. Pantelis, M. De Hert, M. Krebs, 2020, Epidemiology and Psychiatric Sciences.

Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies

H. Möller, W. Maier, I. Heuser, 2016, European Archives of Psychiatry and Clinical Neuroscience.

Are self-experienced neuropsychological deficits able to indicate a liability to schizophrenia? Results of a comparative study of 1st-degree relatives of schizophrenics

J. Klosterkötter, E. Steinmeyer, F. Schultze-Lutter, 1998, Schizophrenia Research.

Neurocognitive functioning in parents of schizophrenia patients: Attentional and executive performance vary with genetic loading

W. Maier, U. Ettinger, M. Wagner, 2015, Psychiatry Research.

Early improvement as a predictor of remission and response in schizophrenia: Results from a naturalistic study

H. Möller, W. Maier, I. Heuser, 2009, European Psychiatry.

Changes in Nutritional Status after Deep Brain Stimulation of the Nucleus Basalis of Meynert in Alzheimer's Disease--Results of a Phase I Study.

H. Freund, V. Visser-Vandewalle, M. Hellmich, 2015, The journal of nutrition, health & aging.

Evaluating depressive symptoms and their impact on outcome in schizophrenia applying the Calgary Depression Scale

H. Möller, W. Maier, I. Heuser, 2011, Acta psychiatrica Scandinavica.

Influencing factors and predictors of early improvement in the acute treatment of schizophrenia and schizophrenia spectrum disorder.

H. Möller, W. Maier, I. Heuser, 2011, Journal of Psychiatric Research.

[Basic symptoms and end phenomena of schizophrenia. An empirical study of psychopathologic transitional signs between deficit and productive symptoms of schizophrenia].

J. Klosterkötter, 1988, Monographien aus dem Gesamtgebiete der Psychiatrie.

Challenging the understanding of significant improvement and outcome in schizophrenia – the concept of reliable and clinically significant change methods

H. Möller, W. Maier, I. Heuser, 2016, International journal of methods in psychiatric research.

Perceived parental rearing in subjects with obsessive–compulsive disorder and their siblings

U. John, P. Falkai, W. Maier, 2010, Acta psychiatrica Scandinavica.

Harm avoidance in subjects with obsessive-compulsive disorder and their families.

Michael Wagner, Peter Falkai, Stephan Ruhrmann, 2008, Journal of affective disorders.

Hemoglobin-Independent Organ Protection by EPO in Humans: Amelioration of Cognitive Loss in Chronic Schizophrenia

J. Aldenhoff, P. Falkai, W. Maier, 2007 .

Positive or negative symptoms — which are more appropriate as diagnostic criteria for schizophrenia?

H. Sass, J. Klosterkötter, E. Steinmeyer, 1995, Acta psychiatrica Scandinavica.

Title Sleep deprivation increases oleoylethanolamide in human cerebrospinal fluid Permalink

M. Hellmich, R. Graf, J. Klosterkötter, 2009 .

Remission in schizophrenia — What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression

H. Möller, W. Maier, I. Heuser, 2019, Schizophrenia Research.

Response trajectories in “real-world” naturalistically treated schizophrenia patients

H. Möller, W. Maier, I. Heuser, 2012, Schizophrenia Research.

Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol

H. Möller, F. Schneider, W. Maier, 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

The early phase of schizophrenia and prediction of outcome

J. Klosterkötter, G. Huber, G. Gross, 1998 .

[Motivational interviewing for patients with comorbid schizophrenia and substance abuse disorders: a review].

E. Gouzoulis-Mayfrank, J. Klosterkötter, A. Bechdolf, 2005, Fortschritte der Neurologie-Psychiatrie.

[Services for the early recognition of psychoses and bipolar disorders in Germany: inventory survey study].

G. Juckel, F. Jessen, A. Pfennig, 2015, Der Nervenarzt.

DRGs und Psych-PV

J. Klosterkötter, 2003, Fortschritte der Neurologie Psychiatrie.

WC2G ACUTE SYMPTOMATIC TREATMENT EFFECTS IN PERSONS CLINICALLY AT RISK FOR PSYCHOSIS

W. Maier, W. Gaebel, J. Klosterkötter, 2006, Schizophrenia Research.

Rates and predictors of remission in first-episode schizophrenia within 1year of antipsychotic maintenance treatment. Results of a randomized controlled trial within the German Research Network on Schizophrenia

H. Möller, P. Falkai, W. Maier, 2014, Schizophrenia Research.

A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients

M. Rietschel, W. Maier, W. Gaebel, 2010, European Neuropsychopharmacology.

Obsessive-Compulsive Disorder and Posttraumatic Stress Disorder

U. John, P. Falkai, W. Maier, 2007, Psychopathology.

Is there a diagnosis-specific influence of childhood trauma on later educational attainment? A machine learning analysis in a large help-seeking sample.

K. Vogeley, J. Kambeitz, J. Klosterkötter, 2021, Journal of psychiatric research.

Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophrenia

Martin Hellmich, Stephan Ruhrmann, Joachim Klosterkötter, 2009, European Archives of Psychiatry and Clinical Neuroscience.

[From fighting to preventing disease. Is such a paradigm possible for schizophrenic disorders?].

J. Klosterkötter, 1998, Fortschritte der Neurologie-Psychiatrie.

Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.

H. Möller, J. Brinkmeyer, W. Maier, 2011, Schizophrenia bulletin.

Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study.

G. Juckel, A. Heinz, J. Klosterkötter, 2010, Archives of general psychiatry.

At risk or not at risk? A meta‐analysis of the prognostic accuracy of psychometric interviews for psychosis prediction

T. McGlashan, S. Woods, P. McGuire, 2015, World psychiatry : official journal of the World Psychiatric Association.

(Attenuated) hallucinations join basic symptoms in a transdiagnostic network cluster analysis

K. Vogeley, E. Meisenzahl, J. Kambeitz, 2022, Schizophrenia Research.

Coping as a predictor of treatment outcome in people at clinical high risk of psychosis

H. Möller, W. Maier, W. Gaebel, 2016, Early intervention in psychiatry.

Childhood adversity predicts persistence of suicidal thoughts differently in females and males at clinical high‐risk patients of psychosis. Results of the EPOS project

G. Juckel, J. Hietala, J. Klosterkötter, 2018, Early intervention in psychiatry.

Prevalence of metabolic syndrome in female and male patients at risk of psychosis

G. Juckel, F. Schneider, W. Maier, 2017, Schizophrenia Research.

The interaction of working memory and emotion in persons clinically at risk for psychosis: An fMRI pilot study

U. Habel, F. Schneider, T. Kellermann, 2010, Schizophrenia Research.

RATIONALE AND BASELINE CHARACTERISTICS OF PREVENT: A SECOND GENERATION INTERVENTION TRIAL IN SUBJECTS AT-RISK (PRODROMAL) OF DEVELOPING FIRST EPISODE PSYCHOSIS EVALUATING COGNITIVE BEHAVIOUR THERAPY, ARIPIPRAZOLE AND PLACEBO FOR THE PREVENTION OF PSYCHOSIS

F. Schneider, W. Maier, A. Heinz, 2011, Schizophrenia Research.

A stratified model for psychosis prediction in clinical practice.

J. Klosterkötter, S. Ruhrmann, F. Schultze-Lutter, 2014, Schizophrenia bulletin.

Predictors of response and remission in the acute treatment of first-episode schizophrenia patients — Is it all about early response?

H. Möller, F. Schneider, I. Heuser, 2011, European Neuropsychopharmacology.

The Dark Side of the Moon: Meta-analytical Impact of Recruitment Strategies on Risk Enrichment in the Clinical High Risk State for Psychosis

T. McGlashan, P. McGuire, D. Perkins, 2015, Schizophrenia bulletin.

Identifying gene-environment interactions in schizophrenia: contemporary challenges for integrated, large-scale investigations.

D. Rujescu, M. Ruggeri, S. Tosato, 2014, Schizophrenia bulletin.

[The concept of process activity in idiopathic psychoses].

J. Klosterkötter, G. Huber, G. Gross, 1989, Der Nervenarzt.

Endogenous cannabinoids and their neurobiological and functional role in schizophrenia spectrum disorders

J. Klosterkötter, D. Piomelli, F. Leweke, 2004 .

Can self‐experienced neuropsychological deficits indicate propensity to schizophrenic psychosis? Results of an 8‐year prospective follow‐up study

J. Klosterkötter, E. Steinmeyer, F. Schultze-Lutter, 1998 .

Management and Outcome of Pallidal Deep Brain Stimulation in Severe Huntington’s Disease

V. Sturm, L. Timmermann, D. Lenartz, 2013, Fortschritte der Neurologie · Psychiatrie.

The nucleus accumbens: a target for deep brain stimulation in obsessive–compulsive- and anxiety-disorders

V. Sturm, D. Lenartz, K. Herholz, 2003, Journal of Chemical Neuroanatomy.